IsoTis raises $5 million in private placement:
This article was originally published in Clinica
Executive Summary
IsoTis, a privately-owned Dutch company researching bioimplant coating technology and tissue engineering, has raised Fl10 million ($5 million) from its shareholders in a private placement. The money - from investors such as Atlas Ventures, GIMV and 3i - will enable the company, based in Bilthoven, to enlarge its R&D and clean room facilities.